OPKO Health acquires CURNA
CURNA is engaged in the discovery of new drugs for the treatment of illnesses such as cancer, heart disease, metabolic disorders and genetic anomalies. Its broad platform technology
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.